Totally Implantable Venous Access Ports (TIVAP) are specialized devices designed for long-term venous therapy, widely used in oncology and other groups requiring prolonged intravenous access. Since their introduction into routine clinical practice in China, they have significantly enhanced the safety and comfort of vascular access management. However, substantial challenges remain in TIVAP utilization as China lacks a unified regulatory framework and standardized full-lifecycle management protocols. Significant disparities also exist among medical institutions in terms of surgical techniques, complication management, and surveillance, leading to inconsistent outcomes and patient satisfaction. This narrative review presents a review of TIVAP clinical applications and maintenance, incorporating the latest evidence-based strategies for implantation and complication mitigation. The objective is to provide a comprehensive reference for optimizing clinical decision-making, minimizing adverse events, and improving patient quality of life.
Reference:Yu A, Pang R, Zhang M, Yin L, Bai X, Jin Y, Sun X. Research progress and narrative review of totally implantable venous access ports. Front Oncol. 2026 Apr 24;16:1800754. doi: 10.3389/fonc.2026.1800754. PMID: 42109644; PMCID: PMC13154220.